Literature DB >> 16800731

The role of kallikrein-related peptidases in prostate cancer: potential involvement in an epithelial to mesenchymal transition.

Astrid K Whitbread1, Tara L Veveris-Lowe, Mitchell G Lawrence, David L Nicol, Judith A Clements.   

Abstract

Several members of the kallikrein-related peptidase family of serine proteases have proteolytic activities that may affect cancer progression; however, the in vivo significance of these activities remains uncertain. We have demonstrated that expression of PSA or KLK4, but not KLK2, in PC-3 prostate cancer cells changed the cellular morphology from epithelial to spindle-shaped, markedly reduced E-cadherin expression, increased vimentin expression and increased cellular migration. These changes are indicative of an epithelial to mesenchymal transition (EMT), a process important in embryonic development and cancer progression. The potential novel role of kallikrein-related peptidases in this process is the focus of this brief review.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16800731     DOI: 10.1515/BC.2006.089

Source DB:  PubMed          Journal:  Biol Chem        ISSN: 1431-6730            Impact factor:   3.915


  15 in total

1.  Hepatocyte growth factor increases the invasive potential of PC-3 human prostate cancer cells via an ERK/MAPK and Zeb-1 signaling pathway.

Authors:  Yili Han; Yong Luo; Yongxing Wang; Yatong Chen; Mingchuan Li; Yongguang Jiang
Journal:  Oncol Lett       Date:  2015-11-18       Impact factor: 2.967

2.  Large-scale exploration of gene-gene interactions in prostate cancer using a multistage genome-wide association study.

Authors:  Julia Ciampa; Meredith Yeager; Laufey Amundadottir; Kevin Jacobs; Peter Kraft; Charles Chung; Sholom Wacholder; Kai Yu; William Wheeler; Michael J Thun; W Ryan Divers; Susan Gapstur; Demetrius Albanes; Jarmo Virtamo; Stephanie Weinstein; Edward Giovannucci; Walter C Willett; Geraldine Cancel-Tassin; Olivier Cussenot; Antoine Valeri; David Hunter; Robert Hoover; Gilles Thomas; Stephen Chanock; Nilanjan Chatterjee
Journal:  Cancer Res       Date:  2011-03-03       Impact factor: 12.701

3.  Genome-wide analysis of androgen receptor binding and gene regulation in two CWR22-derived prostate cancer cell lines.

Authors:  Honglin Chen; Stephen J Libertini; Michael George; Satya Dandekar; Clifford G Tepper; Bushra Al-Bataina; Hsing-Jien Kung; Paramita M Ghosh; Maria Mudryj
Journal:  Endocr Relat Cancer       Date:  2010-10-05       Impact factor: 5.678

4.  The impaired viability of prostate cancer cell lines by the recombinant plant kallikrein inhibitor.

Authors:  Joana Gasperazzo Ferreira; Paula Malloy Motta Diniz; Cláudia Alessandra Andrade de Paula; Yara Aparecida Lobo; Edgar Julian Paredes-Gamero; Thaysa Paschoalin; Amanda Nogueira-Pedro; Paloma Korehisa Maza; Marcos Sergio Toledo; Erika Suzuki; Maria Luiza Vilela Oliva
Journal:  J Biol Chem       Date:  2013-03-19       Impact factor: 5.157

5.  Oncogenic role of DDX3 in breast cancer biogenesis.

Authors:  M Botlagunta; F Vesuna; Y Mironchik; A Raman; A Lisok; P Winnard; S Mukadam; P Van Diest; J H Chen; P Farabaugh; A H Patel; V Raman
Journal:  Oncogene       Date:  2008-02-11       Impact factor: 9.867

6.  Transcription profiling provides insights into gene pathways involved in horn and scurs development in cattle.

Authors:  Maxy Mariasegaram; Antonio Reverter; Wes Barris; Sigrid A Lehnert; Brian Dalrymple; Kishore Prayaga
Journal:  BMC Genomics       Date:  2010-06-11       Impact factor: 3.969

7.  Rapamycin prevents endothelial cell migration by inhibiting the endothelial-to-mesenchymal transition and matrix metalloproteinase-2 and -9: an in vitro study.

Authors:  Hua Gao; Jingjing Zhang; Ting Liu; Weiyun Shi
Journal:  Mol Vis       Date:  2011-12-24       Impact factor: 2.367

8.  Overexpression of myosin VI in prostate cancer cells enhances PSA and VEGF secretion, but has no effect on endocytosis.

Authors:  C Puri; M V Chibalina; S D Arden; A J Kruppa; J Kendrick-Jones; F Buss
Journal:  Oncogene       Date:  2009-10-26       Impact factor: 9.867

9.  Identification of novel androgen receptor target genes in prostate cancer.

Authors:  Unnati Jariwala; Jennifer Prescott; Li Jia; Artem Barski; Steve Pregizer; Jon P Cogan; Armin Arasheben; Wayne D Tilley; Howard I Scher; William L Gerald; Grant Buchanan; Gerhard A Coetzee; Baruch Frenkel
Journal:  Mol Cancer       Date:  2007-06-06       Impact factor: 27.401

10.  Gene discovery for the carcinogenic human liver fluke, Opisthorchis viverrini.

Authors:  Thewarach Laha; Porntip Pinlaor; Jason Mulvenna; Banchob Sripa; Manop Sripa; Michael J Smout; Robin B Gasser; Paul J Brindley; Alex Loukas
Journal:  BMC Genomics       Date:  2007-06-22       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.